AFMD earnings call for the period ending June 30, 2019.
News & Analysis: Affimed Therapeutics
The immune cells live up to their name in natural settings, but engineered therapies have delivered mixed results in clinical trials.
AFMD earnings call for the period ending March 31, 2019.
AFMD earnings call for the period ending December 31, 2018.
The Cinderella biopharma shot up 246% a few days ago, so things aren't so bad.
Affimed struck a game-changing deal with Roche yesterday, causing its shares to sky-rocket.